Evidence map›Paper›PMID 19084101›Full record

ArticleAmerican journal of obstetrics and gynecology2008

Outcomes of combination treatment of fecal incontinence in women.

Alayne D Markland, Holly E Richter, Kathryn L Burgio, Thomas L Wheeler, David T Redden, Patricia S Goode

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03543566 (Antimuscarinic Medication for Urgency Urinary Incontinence in Women With Dual Incontinence), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03543566 completednot on this mapstarted 2018, after this paper: background citation

Antimuscarinic Medication for Urgency Urinary Incontinence in Women With Dual Incontinence (Darifenacin for Treatment of Women With Dual Incontinence)

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2018 to 2019Enrolled32ConditionsUrinary Incontinence, Urge, Fecal Incontinence
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Prevalence and predictive factors of fecal incontinence.Journal of neurogastroenterology and motility · 2012
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alayne D MarklandDivision of Gerontology, Geriatrics and Palliative Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Holly E Richter
Kathryn L Burgio
Thomas L Wheeler
David T Redden
Patricia S Goode
University of Alabama at Birmingham · USGeriatric Research Education and Clinical Center · US

Funding

Zevalin Radioimmunotherapy Using a Modified TreatmentM01RR000032 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RICH, ROBERT R. · 1985 to 2008
$23.6M
Mid Career Award in Patient Oriented Pelvic Floor ResearchK24DK068389 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RICHTER, HOLLY E · 2005 to 2014
$1.7M
NCRR NIH HHS M01 RR000032NCRR NIH HHS M01 RR-00032NIDDK NIH HHS K24 DK068389NIDDK NIH HHS K24DK068389-03
6 · The paper itself

Abstract

objectiveTo describe how women with fecal incontinence (FI) respond to combined pharmacologic therapy and pelvic floor muscle exercises (PFME). STUDY

designValidated questionnaires (Fecal Incontinence Severity Index and Modified Manchester Health Questionnaire) were mailed to 80 women who received combined therapy for FI and had complete baseline assessments. Regression models were constructed to identify predictors of change in questionnaire scores.

resultsResponse rate was 69%. Mean age was 59 +/- 12 years. All women were taught PFME with digital palpation, and 87% of the women received medications. FI severity scores and quality-of-life (QOL) improved from baseline to follow-up (P < .001 and P = .02, respectively). A fair/normal external anal sphincter (EAS) contraction resulted in greater improvements in FI severity (13 points, P = .006) and QOL scores (22 points, P < .001).

conclusionFI severity and QOL improved after combination therapies, and a fair/normal EAS contraction predicted greater improvement.

Indexed as

ExerciseQuality of LifeAdultAgedAged, 80 and overAge FactorsBehavior TherapyChi-Square DistributionCohort StudiesCombined Modality TherapyFecal IncontinenceFemaleHumansLinear ModelsLoperamideMiddle AgedLoperamide

Identifiers

PMID19084101
PMCPMC2658878
OpenAlexW2079865395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.